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Vasopressin stimulates the liberation of labelled inositol phosphate in partially purified plasma membranes 
prepared from myo-[3H]inositol prelabelled WRKl cells. This stimulatory effect was very rapid (165 96 stimu- 
lation of inositol trisphosphate accumulation after a 10 s incubation period in the presence of 1 ,uM vaso- 
pressin), concentration dependent (EC%= 12 nM) and was abolished by an antagonist of the vasopressor 
response to vasopressin. GTP, even at high concentrations (0.1 mM), did not increase inositol phosphate 
release: it was found to be absolutely necessary for hormonal striation of phosphoIipase C activity. Non- 
hydrolysable analogues of GTP may also stimulate this enzyme activity. 
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1. INTRODUCTION 
Many hormones and neurotransmitters exert 
their biological actions through the mobilization of 
intracellular calcium (review see [ 11). It is now well 
established that calcium mobilization is the conse- 
quence of receptor-mediated phospholipase C ac- 
tivity which specifically hydrolyses inositol lipids 
(review see [2]). Inositol trisphosphate, a product 
of PIP2 breakdown, induces the release of calcium 
from intracellular stores [2,3]. The molecular 
mechanisms involved in the hormonal activation 
of phospholipase C have not yet been elucidated. 
Yet, there is evidence suggesting a possible role for 
Abbreviat~a~: IPl , inositol monophosphate; IP2, in- 
ositol bisphosphate; IP3, inositoi trisphosphate; PI, 
phosphatidylinositol; PIP, phosphatidylinosito1 4-phos- 
phate; PIPZ, phosphatidylinositol 4.5bisphosphate; 
LVP, lysine vasopressin; GTP+, guanosine 5’-O-thio- 
triphosphate; GPP(NH)P, guanyl-5 ’ -yl imidodi- 
phosphate; des-Gly’-d(CH&AVP, desglycine9-jl-& 
mer~pto-~~-cyclopentamethyiene propionic acid]- 
arginine vasopressin 
a GTP binding protein in these activation 
cesses [4-61. 
In an earlier report 171, we showed 
pro- 
that 
vasopressin induces inositol phospholipid break- 
down in a rat rn~rn~ tumor cell line (WRKl). 
The results presented here in a partially purified 
preparation of WRKl plasma membrane, demon- 
strate that vasopressin stimulates phospholipase C 
activity in a GTP-dependent manner. 
2. MATERIALS AND METHODS 
2.1. Products 
GTP, GppNHP and GTPyS were purchased 
from Boehringer, lysine vasopressin from Bachem, 
~~o-[3H]inositol (16.5 Cifmol) from New Eng- 
land Nuclear, Eagle’s minimum essential medium 
(MEM) and calf fetal serum from Gibco; Dowex, 
1 x 10 (100-200 mesh, chloride form) from Fluka. 
Des-Gly’d(CH&AVP, a potent vasopressor an- 
tagonist [8], was a generous gift from Dr M. Man- 
ning (Toledo, USA). 
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2.2. Membrane preparation 
WRKl cells were established by Monaco et al. 
[9] and grown in monolayer cultures 4 days in 
MEM medium contai~ng 5% fetal calf serum, 2% 
rat serum, glutamine (292 mg/l), penicillin (100 
units/ml), streptomycin (100 mg/ml) and myo- 
[3H]inositol (1.5 yCi/ml). The culture medium was 
changed 2 days after seeding. 1 h before the experi- 
ment, cells were placed in a culture medium de- 
prived of myo-[3H]inositol, rat and calf serum. 
Cells were washed 3 times at 0°C with phos- 
phate-buffered saline (PBS) without calcium and 
magnesium, scraped at 0°C with a rubber police- 
man into the following medium: 25 mM LiCl, 
0.5 mM EDTA, 10 mM Tris-HCI (PH 7.4) and 0.1 
mM ATP and homogenized at 4°C in a Dounce 
Potter homogenizer equipped with a loose piston 
(15fold). After a rapid centrifugation (5 min, 
100 x g), the pellet was discarded and the super- 
natant subjected to a second centrifugation (15 
min, 30000 x g, O*C). The final pellet was 
resuspended in the same buffer and used imme- 
diately. 
2.3. Electron microscopic con trots 
WRKI membrane pellet was fixed in a 5% 
glut~~dehyde solution buffered with 0.1 N 
cacodylate (pH 7.0), post-fixed in the same buffer 
with 1% osmium tetroxide, dehydrated in alcohol 
and embedded in Spurr resin. Ultrathin sections 
stained with uranyl acetate and lead citrate were 
examined in a Jeol 2000 EX electron microscope. 
As seen in fig. 1, the preparation lacked intact or 
partially lysed cells. It was constituted essentially 
of plasma membranes with few cytoplasmic con- 
taminants (Golgi elements, mitochondria and en- 
doplasmic reticulum). 
2.4. Assay 0~ ph~spho~ip~e C activity 
Membranes prepared from prelabelled WRKl 
cells (30~60,eg protein per assay) were incubated 
at 37°C in 300~1 in a medium similar to that 
described by Litosch et al. [.5]. It was composed of 
25 mM LiCI, 0.1 mM ATP, 0.25 mM EDTA, 
5 mM Tris-HC!l (pH 7.4), 50 mM Na-phosphate 
buffer (pH 7.0), 1 PM CaCls, 5 mM MgCls. When 
specified vasopressin and/or guanyl nucleotide 
were added. The reaction was stopped by the addi- 
tion of 300 /cl of 10% HCl04, 100 ~1 of 20 mg/ml 
BSA and the cooling of the tube to 0°C. The pH 
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Fig. 1. An electron micrograph of the WRKI membrane 
prepration. Bar, 500 nm. 
of the extract was adjusted to 7.0 by adding 0.1 M 
KOH. After a rapid ~entrifugat~on f the He104 
extracts, IPl, IP2 and IP3 present in the superna- 
tant were separated by chromatography on 
Dowex, 1 x 10 (100-200 mesh, formate form) col- 
umns (4.0 x 0.6 cm) by sequential elutions as 
described by Berridge et al. [lo] with minor 
modi~~ations [ 111. This protocol was established 
using purified labelled IPl, IP.2 and IP3 obtained 
from Dr C. Kirk (Birmingham, England). Labelled 
inositol lipids were determined after chloro- 
form/methanol/HCl (100: 100: 1) extraction and 
deacylation in the presence of NaOH as described 
earlier by Creba et al. [ 121. Radioactivity found in 
the IPl, IP2 and IP3 fractions was measured by 
liquid scintillation spectrometry. All results were 
corrected for quenching and expressed in dpm, 
They represent the mean f SE of 3 distinct 
determinations. 
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3. RESULTS AND DISCUSSION 
Fig.2 shows the kinetic evolution of inositol 
lipids present in the WRKl membrane preparation 
as well as inositol phosphate accumulation in the 
incubation medium. Under control conditions (in 
the absence of vasopressin) the membrane amount 
of PI and PIP remained stable. A slight but signifi- 
cant decrease in PIP2 was observed. The relative 
proportions of PI, PIP and PIP2 in membranes 
prepared from WRKl cells are not markedly dif- 
ferent from those found in intact cells (not shown), 
suggesting that no preferential breakdown of one 
of these 3 inositol lipids occurs during the course 
of membrane preparation. The reduction in PIP2 
content was accompanied by a progressive and 
almost linear accumulation of IP2 and IP3. There 
was a fairly good correlation between the amount 
of PIP2 which disappeared uring the 30 min in- 
cubation period and the amount of IP2 + IP3 
which accumulated. All together these observa- 
tions suggest the presence in this membrane 
-- I- 
Time (mrtl 
Fig.2. The time course of the accumulation of inositol 
phosphates and the breakdown of phosphoinositol ipids 
in WRKl membranes. Membranes prepared from 
WRKl cells were grown 4 days in the presence of myo- 
[3H]inositol and were incubated in the presence of 
0.1 mM GTP for various times at 37’C with (0) or 
without (0) 0.2pM LVP (see section 2). Inositol 
phosphates (left panel) and phosphoinositol ipids (right 
panel) were determined as indicated in section 2. 
preparation of a phospholipase C activity using 
PIP2 as a substrate. They are compatible with the 
hypothesis that IP2 originates from IP3 hydrolysis 
rather than from an enzyme attack on PIP. IPl 
content increased at a very slow rate. The origin of 
IPl found at zero time is not clear. It might have 
resulted from a slow inositol lipid breakdown dur- 
ing the process of membrane preparation. 
In the presence of vasopressin, a marked but 
transient increase in IP3 accumulation apd a more 
sustained increase in IP2 accumulation were 
observed (fig.2). The amounts of IP2 and IP3 
which accumulated were about twice the observed 
reduction in PIP2 and PIP content, suggesting that 
PIP and PIP2 are produced by PI phosphorylation 
during the 30 min incubation period. The rapid 
fade of the vasopressin response may be a conse- 
quence of a rapid reduction in the amount of the 
phospholipase C specific substrate. Indeed, studies 
of Monaco et al. [13] on WRKl cells indicate that 
only a fraction of the PI pool is sensitive to 
vasopressin-induced breakdown. 
Nevertheless, the experiment illustrated in fig.2 
clearly shows that vasopressin-induced inositol 
lipid breakdown can be demonstrated using 
acellular preparations derived from prelabelled 
WRKl cells. Based on the results shown in fig.2, a 
6 min incubation period was chosen for all further 
experiments. 
As shown in table 1, the vasopressin-sensitive 
phospholipase C in WRKl cell membranes is ac- 
tivated by guanyl nucleotides. The non- 
hydrolysable GTP analogues, Gpp(NH)p and 
GTPyS produced a marked stimulation of IP2 and 
IP3 formation, while GTP was inactive. The most 
salient result shown in table 1 is that LVP, when 
added in the absence of GTP, was almost inactive. 
In the presence of GTP (0.1 mM), vasopressin in- 
duced a 3-4-fold increase in IP2 and IP3 forma- 
tion. The responses to vasopressin + GTP and 
GTPyS were of a similar magnitude. 
The data presented in fig.3 show that in the 
presence of 0.1 mM GTP, the stimulation of 
phospholipase C by vasopressin was concentration 
dependent. The vasopressin-induced IP3 ac- 
cumulation (426 f 116% of basal values) was more 
pronounced than the increase in IP2 and IPl ac- 
cumulations (271 + 50 and 116 + 16070, respective- 
ly). Yet, the concentration of vasopressin leading 
to the half-maximum response (E&) was identical 
157 
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Table 1 
Effect of guanyl nucleotides, vasopressin and vasopressin antagonist on the phospholipase C activity present in WRKI 
cell membranes 
Additions Inositol phosphate accumulation 
(dpm per assay) 
Hormone Nucleotide 
IPl IP2 IP3 
- - 515 f 31 285 f 15 146 f 16 
_ 0.1 mM GTP 542 f 7 305 f 10 17Ok 8 
_ 0.1 mM Gpp(NH)p 576 + 50 506 f 38 209 + 20 
_ 0.1 mM GTPyS 603 f 76 869 f 48 517 * 12 
0.1 PM LVP - 484 f 19 383 f 8 175 f 13 
0.1 PM LVP 0.1 mM GTP 494 f 4 966 f 56 636 + 43 
0.6 pM des-Glyg-d(CH&AVP 0.1 mM GTP 472 f 25 292 f 21 175 + 14 
0.1 mM des-Glyg-d(CH&AVP 
+ O.lpM LVP _ 482 f 53 248 f 20 140 f 17 
myo-[‘H]Inositol prelabelled WRKl membranes (50,~g per assay) were incubated for 6 min at 37°C in the presence of 
the indicated effecters. Inositol phosphates (IPl, IP2 and IP3) liberated in the medium were determined as indicated 
in section 2 
I 
m Yo -9 -8 -7 -6 
LVP (Log[MI) 
Fig.3. Dose-dependent activation of phospholipase C by 
vasopressin. myo-[‘H]Inositol prelabelled WRKl 
membranes were incubated in the presence of 0.1 mM 
GTP for 6 min at 37°C with increasing amounts of 
vasopressin. Inositol phosphates liberated in the 
incubation medium were determined (see section 2). 
regardless of the inositol phosphate considered. 
The mean EC50 values derived from 3 independent 
determinations were 13 f 3 and 12 + 4 nM for IP3 
and IP2, respectively. These values are very close 
to the dissociation constant (&) determined for 
[3H]lysine-vasopressin binding to WRKl mem- 
branes derived from these cells (& = 10 nM, 
Guillon et al., personal communication). 
Moreover, the vasopressin-induced IP2 and IP3 
accumulation could be completely inhibited by the 
vasopressin antagonists des-Gly’-d(CH&AVP 
(table 1). The observed vasopressin effect on 
phospholipase C thus appeared to be receptor 
mediated. 
In conclusion, we demonstrate the presence of a 
guanyl nucleotide and hormone-sensitive phos- 
pholipase C in a plasma membrane fraction de- 
rived from WRKl cells. 
Our results confirm the previous studies of 
Wallace and Fain [14] in rat liver membranes 
showing a vasopressin-induced phosphatidyl- 
inositol breakdown. Moreover, they are in good 
agreement with those of Litosch and co-workers 
[5] who demonstrated, in a blowfly salivary gland 
membrane preparation, the presence of a GTP 
and serotonin-sensitive stimulation of inositol 
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phosphate production. Activation of phospho- 
lipase C by non-hydrolysable analogues of GTP 
was also described in other systems [6,15]. All 
together these data indicate that GTP binding pro- 
tein(s) is (are) probably involved in mediating the 
effect of hormones that act via the breakdown of 
phosphoinositides. In line with this hypothesis, it is 
interesting to mention that vasopressin binding to 
WRKl cells and liver membrane is sensitive to 
GTP ([16] and unpublished). The role and the 
nature of the putative GTP binding protein(s) in- 
volved in these mechanisms remain unclear. By 
analogy with hormonally regulated adenylate 
cyclase systems, this (these) protein(s) may exhibit 
a GTPase activity and may be responsible for the 
reversal of phospholipase C activation. Such a 
hypothesis would account for the marked activa- 
tion induced by the non-hydrolysable analogues of 
GTP, Gpp(NH)p and GTPyS (see table 1). 
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